Sustained Release of Basic Fibroblast Growth Factor (bFGF) Encapsulated Polycaprolactone (PCL) Microspheres Promote Angiogenesis In Vivo

Coronary heart disease (CHD) is the leading cause of death in the Unites States and globally. The administration of growth factors to preserve cardiac function after myocardial infarction (MI) is currently being explored. Basic fibroblast growth factor (bFGF), a potent angiogenic factor has poor cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Arunkumar, Pala, Dougherty, Julie A., Weist, Jessica, Kumar, Naresh, Angelos, Mark G., Powell, Heather M., Khan, Mahmood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669517/
https://www.ncbi.nlm.nih.gov/pubmed/31330782
http://dx.doi.org/10.3390/nano9071037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669517/
https://www.ncbi.nlm.nih.gov/pubmed/31330782
http://dx.doi.org/10.3390/nano9071037

Ejemplares similares